Abstract
In this issue of Blood, Didigu et al explore a potential strategy for HIV cure that uses gene therapy to simultaneously inactivate both cellular coreceptors used for viral entry: CC chemokine receptor 5 (CCR5) and CXC chemokine receptor 4 (CXCR4).
Original language | English (US) |
---|---|
Pages (from-to) | 2-3 |
Number of pages | 2 |
Journal | Blood |
Volume | 123 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2 2014 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology